CPT® Code 86684

1. Indications

The antibody test for Haemophilus influenzae type B (HIB) is indicated for several specific clinical scenarios, particularly in assessing the immune response to vaccination and evaluating potential immunodeficiency. The following conditions may warrant the use of this test:

• Post-Vaccination Assessment This test is performed to determine the immune status of a patient following vaccination against HIB, ensuring that the individual has developed adequate antibody levels to provide protection against infections caused by this bacterium.
• Evaluation of Immunodeficiency The test aids in the diagnosis of immunodeficiency response syndromes, where the patient's immune system may not respond effectively to vaccinations or infections, thereby increasing the risk of severe diseases associated with H. influenzae.
• Monitoring High-Risk Populations It is particularly relevant for children under the age of 5 years, who are at a higher risk for severe infections caused by H. influenzae type B, allowing for timely intervention if antibody levels are found to be insufficient.

2. Procedure

The procedure for conducting the antibody test for Haemophilus influenzae type B involves several key steps that ensure accurate measurement of IgG antibodies in the serum. The following outlines the procedural steps:

• Step 1: Patient Preparation Prior to the test, the patient may be instructed to avoid certain medications or supplements that could interfere with the test results. It is essential to ensure that the patient is adequately informed about the procedure and any necessary preparations.
• Step 2: Venipuncture A qualified healthcare professional performs a venipuncture to obtain a blood sample. This involves using a sterile needle to access a vein, typically in the arm, and collecting the blood into a designated collection tube. The venipuncture procedure is crucial as it must be performed with precision to minimize discomfort and ensure an adequate sample for testing.
• Step 3: Serum Separation After the blood sample is collected, it is processed to separate the serum from the cellular components. This is typically done by centrifugation, which spins the blood at high speeds to separate the serum, which contains the antibodies, from the red and white blood cells.
• Step 4: Testing Using ELISA The serum is then subjected to an enzyme-linked immunosorbent assay (ELISA). This laboratory technique involves adding specific antigens related to H. influenzae type B to the serum sample. If antibodies are present, they will bind to the antigens, and a series of reactions will produce a measurable signal, indicating the level of antibodies in the sample.
• Step 5: Result Interpretation Once the ELISA is complete, the results are analyzed and interpreted by laboratory personnel. The presence and concentration of IgG antibodies against HIB are reported, providing critical information regarding the patient's immune status.

3. Post-Procedure

After the procedure, the patient may experience minor discomfort or bruising at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care instructions required for this test, but patients should be advised to monitor the site for any unusual symptoms, such as excessive swelling or pain. The results of the antibody test will be communicated to the healthcare provider, who will discuss the findings with the patient and determine any necessary follow-up actions based on the immune status indicated by the test results.